Advanced Biomed — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Advanced Biomed is a commercial-stage medical device company headquartered in Taipei, Taiwan. It specializes in stents and catheters for cardiovascular and interventional procedures. Little public information is available about its pipeline, funding, or leadership, but it appears to operate in the competitive interventional cardiology market with a focus on accessible, cost-effective devices for Asian and emerging markets.

CardiovascularInterventional

Technology Platform

Medical devices including stents and catheters for cardiovascular and interventional applications.

Opportunities

Expanding into Asian and emerging markets with cost-effective interventional cardiology devices; potential to develop advanced drug-eluting or bioresorbable stent technologies; leveraging Taiwan's strong manufacturing base to compete globally.

Risk Factors

Limited public information increases uncertainty; intense competition from large medical device companies; regulatory and reimbursement challenges across multiple geographies; reliance on a narrow product line.

Competitive Landscape

Dominated by Abbott, Boston Scientific, Medtronic, and regional players like MicroPort. Advanced Biomed likely differentiates through price competitiveness and regional focus, but faces significant scale and brand recognition disadvantages.

More companies in Taiwan →